Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor

Molecular Endocrinology

Volumn 14, Issue 11, 2000, Pages 1776-1787

  Liu, Y Y ^a   Nguyen, C ^a   Peleg, S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; RETINOID X RECEPTOR; STEROID RECEPTOR; VITAMIN D RECEPTOR;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DIMERIZATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ASSAY; STEREOCHEMISTRY;

EID: 0033657518     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.14.11.0560     Document Type: Article

References (43)

1. 3
2. Baculovirus-mediated expression of the human vitamin D receptor: Functional characterization, vitamin D response element interactions and evidence for a receptor auxiliary factor
3. RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements
4. Retinoid x receptor interacts with nuclear receptors in retinoic acid, thyroid, and vitamin D signaling
5. Structural and functional determinants of DNA binding and dimerization by the vitamin D receptor
6. Mapping the domains of the interaction of the vitamin D receptor and steroid receptor coactivator-1
7. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid and vitamin D receptors
8. Isolation and characterization of a novel coactivator protein, NCoA-62, involved in vitamin D-mediated transcription
9. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex
10. 3 are associated with enhanced activation of the vitamin D receptor
11. 3
12. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression
13. 3
14. 3 analogues and their 20-epi homologues with the vitamin D receptor
15. 3 is due to reduced catabolism and altered protein binding
16. Pharmacokinetics studies of vitamin D analogues: Relationship to vitamin D binding protein (DBP)
17. 3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells
18. 3
19. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system
20. 3 are highly potent inducers of DRIP coactivator complex binding to the vitamin D receptor
21. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors
22. Dimerization interfaces of thyroid hormone, retinoic acid, vitamin D and retinoid X receptors
23. The C-terminal region of the vitamin D receptor is essential to form a complex with a receptor auxiliary factor required for high affinity binding to the vitamin D responsive element
24. Vitamin D receptor contains multiple dimerization interfaces that are functionally different
25. Vitamin D-influenced gene expression via a ligand-independent receptor-DNA complex intermediate
26. Difference and similarity of DNA sequence recognized by VDR homodimer and VDR/RXR heterodimer
27. Retinoid x receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast
28. 3 and inhibited by 9-cis-retinoic acid: Evidence for allosteric receptor interactions
29. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor γ
30. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities
31. DNA target selectivity by the vitamin D receptor: Mechanism for dimer binding to an asymmetric repeat element
32. 3 receptor in the absence of the retinoid X receptor
33. Vitamin D receptor homodimer interactions with the murine osteopontin response element
34. 3 analogues is not related to the AP-1 pathway, but related to promoter selectivity
35. 3 and its A ring-modified analogs
36. Molecular basis of agonism and antagonism in the oestrogen receptor
37. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
38. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
39. The DRIP complex, SRC1/p160 coactivators share similar nuclear receptor binding determinants but constitute functionally distinct complexes
40. Isolation and characterization of a novel coactivator protein, NCoA-62, involved in vitamin D-mediated transcription
41. The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand
42. The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets
43. Transcription of the human calcitonin gene is mediated by a C-cell specific enhancer containing E-box-like elements